Project Grant K01DA064877
Award Date 6/15/26
Completion Date 5/31/31
Dollars Obligated $191K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $191,700 Project Grant award dated August 1, 2025, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate an artificial intelligence-driven framework for predicting severe opioid adverse drug effects using automated electronic health record (EHR) data processing. The project, titled "Improving the Prediction of Opioid Outcomes via Automated EHR...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Children's Hospital of Philadelphia Research Institute a $1.068 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the lifespan effects of prenatal and perinatal opioid exposure on the brain's metabolic-epigenetic axis. The research project, which commenced September 1, 2025, and will conclude May 31, 2030, addresses a critical gap in neuroprotective...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $319,770 to the Icahn School of Medicine at Mount Sinai on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a K99/R00 Career Development Award project entitled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project, which runs through June 30, 2027, will deliver research services focused on...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Southern California a $196,236 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate clinician preconceptions about cannabis use during pregnancy and their impact on prenatal care quality. The award funds a five-year research initiative (through June 30, 2030) led by Dr. Rachel Carmen Ceasar that employs natural language processing and artificial...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $199,584 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded March 15, 2026, with an ultimate completion date of February 28, 2031. Under the direction of Dr. Michele Buonora, this five-year mentored research and career development initiative will establish a clinician investigator specializing in implementation science to develop, test,...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $193,644 Project Grant to Columbia University's Health Sciences Division, effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports a multilevel epidemiological research study examining polysubstance use trajectories and overdose risk prediction, utilizing longitudinal data from the National Longitudinal Study of Adolescent to...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $181,092 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with completion targeted for April 30, 2028. This K99/R00 career development award supports fundamental neuroscience research investigating dopamine receptor type 2 (D2)-expressing cells in the ventral hippocampus and their role in cocaine relapse...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $511,396 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2030. The award supports fundamental neuroscience research investigating the diversity of presynaptic function across different neuronal populations, with particular...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $1,517,762 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop safer opioid therapeutics through integrative computational and experimental approaches. The award, effective July 1, 2025, through March 31, 2030, supports research leveraging Bayesian inference frameworks and artificial intelligence tools to understand how...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a K23 Career Development Grant totaling $195,228 to Icahn School of Medicine at Mount Sinai, with an award date of May 1, 2026 and completion date of April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This grant supports Dr. Shastry's development as an independent physician-scientist focused on improving emergency department (ED) care for patients with opioid use disorder (OUD). The...